{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:14:12Z","timestamp":1790176452824,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CMRPG8G0882"],"award-info":[{"award-number":["CMRPG8G0882"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00428-019-02679-6","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T09:04:32Z","timestamp":1573117472000},"page":"121-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["What is new about the molecular genetics in matrix-producing soft tissue tumors? -The contributions to pathogenetic understanding and diagnostic classification"],"prefix":"10.1007","volume":"476","author":[{"given":"Yu-Chien","family":"Kao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Chieh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1216-7751","authenticated-orcid":false,"given":"Hsuan-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"issue":"3","key":"2679_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.path.2015.05.004","volume":"8","author":"SJ Cho","year":"2015","unstructured":"Cho SJ, Horvai A (2015) Chondro-osseous lesions of soft tissue. Surg Pathol Clin 8(3):419\u2013444. https:\/\/doi.org\/10.1016\/j.path.2015.05.004","journal-title":"Surg Pathol Clin"},{"key":"2679_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.anndiagpath.2015.11.002","volume":"20","author":"N Schneider","year":"2016","unstructured":"Schneider N, Fisher C, Thway K (2016) Ossifying fibromyxoid tumor: morphology, genetics, and differential diagnosis. Ann Diagn Pathol 20:52\u201358. https:\/\/doi.org\/10.1016\/j.anndiagpath.2015.11.002","journal-title":"Ann Diagn Pathol"},{"issue":"11","key":"2679_CR3","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1097\/PAS.0b013e3182284a3f","volume":"35","author":"RP Graham","year":"2011","unstructured":"Graham RP, Dry S, Li X, Binder S, Bahrami A, Raimondi SC, Dogan A, Chakraborty S, Souchek JJ, Folpe AL (2011) Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study. Am J Surg Pathol 35(11):1615\u20131625. https:\/\/doi.org\/10.1097\/PAS.0b013e3182284a3f","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2679_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00000478-200304000-00001","volume":"27","author":"AL Folpe","year":"2003","unstructured":"Folpe AL, Weiss SW (2003) Ossifying fibromyxoid tumor of soft parts: a clinicopathologic study of 70 cases with emphasis on atypical and malignant variants. Am J Surg Pathol 27(4):421\u2013431. https:\/\/doi.org\/10.1097\/00000478-200304000-00001","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2679_CR5","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1097\/PAS.0b013e31829644b4","volume":"37","author":"RP Graham","year":"2013","unstructured":"Graham RP, Weiss SW, Sukov WR, Goldblum JR, Billings SD, Dotlic S, Folpe AL (2013) PHF1 rearrangements in ossifying fibromyxoid tumors of soft parts: a fluorescence in situ hybridization study of 41 cases with emphasis on the malignant variant. Am J Surg Pathol 37(11):1751\u20131755. https:\/\/doi.org\/10.1097\/PAS.0b013e31829644b4","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2679_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/gcc.22132","volume":"53","author":"CR Antonescu","year":"2014","unstructured":"Antonescu CR, Sung YS, Chen CL, Zhang L, Chen HW, Singer S, Agaram NP, Sboner A, Fletcher CD (2014) Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors\u2014molecular characterization shows genetic overlap with endometrial stromal sarcoma. Genes Chromosomes Cancer 53(2):183\u2013193. https:\/\/doi.org\/10.1002\/gcc.22132","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2679_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/gcc.22400","volume":"56","author":"YC Kao","year":"2017","unstructured":"Kao YC, Sung YS, Zhang L, Chen CL, Huang SC, Antonescu CR (2017) Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1. Genes Chromosomes Cancer 56(1):42\u201350. https:\/\/doi.org\/10.1002\/gcc.22400","journal-title":"Genes Chromosomes Cancer"},{"key":"2679_CR8","doi-asserted-by":"publisher","unstructured":"Suurmeijer AJH, Song W, Sung YS, Zhang L, Swanson D, Fletcher CDM, Dickson BC, Antonescu CR (2019) Novel recurrent PHF1-TFE3 fusions in ossifying fibromyxoid tumors. Genes Chromosomes Cancer. https:\/\/doi.org\/10.1002\/gcc.22755","DOI":"10.1002\/gcc.22755"},{"issue":"1","key":"2679_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O'Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White KE, Zaino RJ, Weiss SW (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28(1):1\u201330. https:\/\/doi.org\/10.1097\/00000478-200401000-00001","journal-title":"Am J Surg Pathol"},{"key":"2679_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bonr.2017.09.002","volume":"7","author":"P Florenzano","year":"2017","unstructured":"Florenzano P, Gafni RI, Collins MT (2017) Tumor-induced osteomalacia. Bone Rep 7:90\u201397. https:\/\/doi.org\/10.1016\/j.bonr.2017.09.002","journal-title":"Bone Rep"},{"issue":"10","key":"2679_CR11","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s40618-018-0849-5","volume":"41","author":"JM Boland","year":"2018","unstructured":"Boland JM, Tebben PJ, Folpe AL (2018) Phosphaturic mesenchymal tumors: what an endocrinologist should know. J Endocrinol Invest 41(10):1173\u20131184. https:\/\/doi.org\/10.1007\/s40618-018-0849-5","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2679_CR12","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/jbmr.1881","volume":"28","author":"WH Chong","year":"2013","unstructured":"Chong WH, Andreopoulou P, Chen CC, Reynolds J, Guthrie L, Kelly M, Gafni RI, Bhattacharyya N, Boyce AM, El-Maouche D, Crespo DO, Sherry R, Chang R, Wodajo FM, Kletter GB, Dwyer A, Collins MT (2013) Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res 28(6):1386\u20131398. https:\/\/doi.org\/10.1002\/jbmr.1881","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2679_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/his.13377","volume":"72","author":"Y Yamada","year":"2018","unstructured":"Yamada Y, Kinoshita I, Kenichi K, Yamamoto H, Iwasaki T, Otsuka H, Yoshimoto M, Ishihara S, Toda Y, Kuma Y, Setsu N, Koga Y, Honda Y, Inoue T, Yanai H, Yamashita K, Ito I, Takahashi M, Ohga S, Furue M, Nakashima Y, Oda Y (2018) Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant. Histopathology 72(3):460\u2013471. https:\/\/doi.org\/10.1111\/his.13377","journal-title":"Histopathology"},{"issue":"10","key":"2679_CR14","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/PAS.0000000000000890","volume":"41","author":"A Agaimy","year":"2017","unstructured":"Agaimy A, Michal M, Chiosea S, Petersson F, Hadravsky L, Kristiansen G, Horch RE, Schmolders J, Hartmann A, Haller F, Michal M (2017) Phosphaturic mesenchymal tumors: clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum. Am J Surg Pathol 41(10):1371\u20131380. https:\/\/doi.org\/10.1097\/PAS.0000000000000890","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2679_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00795-015-0115-2","volume":"49","author":"S Tajima","year":"2016","unstructured":"Tajima S, Takashi Y, Ito N, Fukumoto S, Fukuyama M (2016) ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors. Med Mol Morphol 49(4):203\u2013209. https:\/\/doi.org\/10.1007\/s00795-015-0115-2","journal-title":"Med Mol Morphol"},{"issue":"7","key":"2679_CR16","first-page":"8159","volume":"8","author":"S Tajima","year":"2015","unstructured":"Tajima S, Fukayama M (2015) CD56 may be a more useful immunohistochemical marker than somatostatin receptor 2A for the diagnosis of phosphaturic mesenchymal tumors. Int J Clin Exp Pathol 8(7):8159\u20138164","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"2679_CR17","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","volume":"44","author":"M Houang","year":"2013","unstructured":"Houang M, Clarkson A, Sioson L, Elston MS, Clifton-Bligh RJ, Dray M, Ranchere-Vince D, Decouvelaere AV, de la Fouchardiere A, Gill AJ (2013) Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Hum Pathol 44(12):2711\u20132718. https:\/\/doi.org\/10.1016\/j.humpath.2013.07.016","journal-title":"Hum Pathol"},{"issue":"8","key":"2679_CR18","first-page":"9390","volume":"8","author":"S Tajima","year":"2015","unstructured":"Tajima S, Fukayama M (2015) Possibility of D2-40 as a diagnostic and tumor differentiation-suggestive marker for some of phosphaturic mesenchymal tumors. Int J Clin Exp Pathol 8(8):9390\u20139396","journal-title":"Int J Clin Exp Pathol"},{"key":"2679_CR19","doi-asserted-by":"publisher","unstructured":"Creytens D, Van Dorpe J (2016) DOG1 expression in phosphaturic mesenchymal tumour. J Clin Pathol. https:\/\/doi.org\/10.1136\/jclinpath-2016-203893","DOI":"10.1136\/jclinpath-2016-203893"},{"key":"2679_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13000-016-0477-3","volume":"11","author":"E Shiba","year":"2016","unstructured":"Shiba E, Matsuyama A, Shibuya R, Yabuki K, Harada H, Nakamoto M, Kasai T, Hisaoka M (2016) Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant. Diagn Pathol 11:26. https:\/\/doi.org\/10.1186\/s13000-016-0477-3","journal-title":"Diagn Pathol"},{"issue":"1","key":"2679_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/PAS.0000000000000290","volume":"39","author":"JM Carter","year":"2015","unstructured":"Carter JM, Caron BL, Dogan A, Folpe AL (2015) A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors. Am J Surg Pathol 39(1):75\u201383. https:\/\/doi.org\/10.1097\/PAS.0000000000000290","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2679_CR22","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","volume":"29","author":"JC Lee","year":"2016","unstructured":"Lee JC, Su SY, Changou CA, Yang RS, Tsai KS, Collins MT, Orwoll ES, Lin CY, Chen SH, Shih SR, Lee CH, Oda Y, Billings SD, Li CF, Nielsen GP, Konishi E, Petersson F, Carpenter TO, Sittampalam K, Huang HY, Folpe AL (2016) Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Mod Pathol 29(11):1335\u20131346. https:\/\/doi.org\/10.1038\/modpathol.2016.137","journal-title":"Mod Pathol"},{"issue":"4","key":"2679_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/path.4465","volume":"235","author":"JC Lee","year":"2015","unstructured":"Lee JC, Jeng YM, Su SY, Wu CT, Tsai KS, Lee CH, Lin CY, Carter JM, Huang JW, Chen SH, Shih SR, Marino-Enriquez A, Chen CC, Folpe AL, Chang YL, Liang CW (2015) Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol 235(4):539\u2013545. https:\/\/doi.org\/10.1002\/path.4465","journal-title":"J Pathol"},{"issue":"8","key":"2679_CR24","first-page":"9422","volume":"8","author":"S Tajima","year":"2015","unstructured":"Tajima S, Fukayama M (2015) Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors. Int J Clin Exp Pathol 8(8):9422\u20139427","journal-title":"Int J Clin Exp Pathol"},{"issue":"11","key":"2679_CR25","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/01.MP.0000092954.42656.94","volume":"16","author":"A Dahlen","year":"2003","unstructured":"Dahlen A, Mertens F, Rydholm A, Brosjo O, Wejde J, Mandahl N, Panagopoulos I (2003) Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 16(11):1132\u20131140. https:\/\/doi.org\/10.1097\/01.MP.0000092954.42656.94","journal-title":"Mod Pathol"},{"key":"2679_CR26","doi-asserted-by":"publisher","unstructured":"Amary F, Perez-Casanova L, Ye H, Cottone L, Strobl AC, Cool P, Miranda E, Berisha F, Aston W, Rocha M, O'Donnell P, Pillay N, Tirabosco R, Baumhoer D, Hookway ES, Flanagan AM (2019) Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement. Mod Pathol.:1\u201310. https:\/\/doi.org\/10.1038\/s41379-019-0315-8","DOI":"10.1038\/s41379-019-0315-8"},{"issue":"4","key":"2679_CR27","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/path.4683","volume":"238","author":"F Puls","year":"2016","unstructured":"Puls F, Hofvander J, Magnusson L, Nilsson J, Haywood E, Sumathi VP, Mangham DC, Kindblom LG, Mertens F (2016) FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma. J Pathol 238(4):502\u2013507. https:\/\/doi.org\/10.1002\/path.4683","journal-title":"J Pathol"},{"issue":"3","key":"2679_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41379-018-0150-3","volume":"32","author":"A Al-Ibraheemi","year":"2019","unstructured":"Al-Ibraheemi A, Folpe AL, Perez-Atayde AR, Perry K, Hofvander J, Arbajian E, Magnusson L, Nilsson J, Mertens F (2019) Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases. Mod Pathol 32(3):423\u2013434. https:\/\/doi.org\/10.1038\/s41379-018-0150-3","journal-title":"Mod Pathol"},{"key":"2679_CR29","first-page":"106","volume-title":"WHO classification of tumours of soft tissue and bone","author":"AM Oliveira","year":"2013","unstructured":"Oliveira AM (2013) Giant cell tumor of soft tissue. In: Fletcher CD, Bridge JA, Hogendoorn PC, Mertens F (eds) WHO classification of tumours of soft tissue and bone, 4th edn. IARC Press, Lyon, pp 106\u2013107","edition":"4"},{"issue":"12","key":"2679_CR30","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/ng.2814","volume":"45","author":"S Behjati","year":"2013","unstructured":"Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, Wedge DC, Cooke SL, Gundem G, Davies H, Nik-Zainal S, Martin S, McLaren S, Goodie V, Robinson B, Butler A, Teague JW, Halai D, Khatri B, Myklebost O, Baumhoer D, Jundt G, Hamoudi R, Tirabosco R, Amary MF, Futreal PA, Stratton MR, Campbell PJ, Flanagan AM (2013) Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45(12):1479\u20131482. https:\/\/doi.org\/10.1038\/ng.2814","journal-title":"Nat Genet"},{"issue":"5","key":"2679_CR31","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/modpathol.2016.236","volume":"30","author":"JC Lee","year":"2017","unstructured":"Lee JC, Liang CW, Fletcher CD (2017) Giant cell tumor of soft tissue is genetically distinct from its bone counterpart. Mod Pathol 30(5):728\u2013733. https:\/\/doi.org\/10.1038\/modpathol.2016.236","journal-title":"Mod Pathol"},{"issue":"3","key":"2679_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/his.13249","volume":"71","author":"I Mancini","year":"2017","unstructured":"Mancini I, Righi A, Gambarotti M, Picci P, Dei Tos AP, Billings SD, Simi L, Franchi A (2017) Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart. Histopathology 71(3):453\u2013460. https:\/\/doi.org\/10.1111\/his.13249","journal-title":"Histopathology"},{"key":"2679_CR33","first-page":"50","volume-title":"WHO classification of tumours of soft tissue and bone","author":"AE Rosenberg","year":"2013","unstructured":"Rosenberg AE, Oliveira AM (2013) Myositis ossificans and fibro-osseous pseudotumor of digits. In: Fletcher CD, Bridge JA, Hogendoorn PC, Mertens F (eds) WHO classification of tumours of soft tissue and bone, 4th edn. IARC Press, Lyon, pp 50\u201351","edition":"4"},{"key":"2679_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.humpath.2019.02.009","volume":"88","author":"M Svajdler","year":"2019","unstructured":"Svajdler M, Michal M, Martinek P, Ptakova N, Kinkor Z, Szepe P, Svajdler P, Mezencev R, Michal M (2019) Fibro-osseous pseudotumor of digits and myositis ossificans show consistent COL1A1-USP6 rearrangement: a clinicopathological and genetic study of 27 cases. Hum Pathol 88:39\u201347. https:\/\/doi.org\/10.1016\/j.humpath.2019.02.009","journal-title":"Hum Pathol"},{"issue":"12","key":"2679_CR35","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1097\/00000478-199912000-00003","volume":"23","author":"JD Wilson","year":"1999","unstructured":"Wilson JD, Montague CJ, Salcuni P, Bordi C, Rosai J (1999) Heterotopic mesenteric ossification ('intraabdominal myositis ossificans'): report of five cases. Am J Surg Pathol 23(12):1464\u20131470. https:\/\/doi.org\/10.1097\/00000478-199912000-00003","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2679_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.pas.0000184820.71752.20","volume":"30","author":"RM Patel","year":"2006","unstructured":"Patel RM, Weiss SW, Folpe AL (2006) Heterotopic mesenteric ossification: a distinctive pseudosarcoma commonly associated with intestinal obstruction. Am J Surg Pathol 30(1):119\u2013122. https:\/\/doi.org\/10.1097\/01.pas.0000184820.71752.20","journal-title":"Am J Surg Pathol"},{"key":"2679_CR37","volume-title":"Practical soft tissue pathology: a diagnostic approach","author":"JL Hornick","year":"2018","unstructured":"Hornick JL (2018) Practical soft tissue pathology: a diagnostic approach. Elsevier\/Saunders, Philadelphia"},{"issue":"1","key":"2679_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00000478-200201000-00007","volume":"26","author":"GP Nielsen","year":"2002","unstructured":"Nielsen GP, Fletcher CD, Smith MA, Rybak L, Rosenberg AE (2002) Soft tissue aneurysmal bone cyst: a clinicopathologic study of five cases. Am J Surg Pathol 26(1):64\u201369. https:\/\/doi.org\/10.1097\/00000478-200201000-00007","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2679_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00256-007-0442-z","volume":"37","author":"WR Sukov","year":"2008","unstructured":"Sukov WR, Franco MF, Erickson-Johnson M, Chou MM, Unni KK, Wenger DE, Wang X, Oliveira AM (2008) Frequency of USP6 rearrangements in myositis ossificans, brown tumor, and cherubism: molecular cytogenetic evidence that a subset of \"myositis ossificans-like lesions\" are the early phases in the formation of soft-tissue aneurysmal bone cyst. Skeletal Radiol 37(4):321\u2013327. https:\/\/doi.org\/10.1007\/s00256-007-0442-z","journal-title":"Skeletal Radiol"},{"issue":"7","key":"2679_CR40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00256-018-3135-x","volume":"48","author":"W Song","year":"2019","unstructured":"Song W, Suurmeijer AJH, Bollen SM, Cleton-Jansen AM, Bovee J, Kroon HM (2019) Soft tissue aneurysmal bone cyst: six new cases with imaging details, molecular pathology, and review of the literature. Skeletal Radiol 48(7):1059\u20131067. https:\/\/doi.org\/10.1007\/s00256-018-3135-x","journal-title":"Skeletal Radiol"},{"issue":"1","key":"2679_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2013.03.005","volume":"45","author":"AM Oliveira","year":"2014","unstructured":"Oliveira AM, Chou MM (2014) USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum Pathol 45(1):1\u201311. https:\/\/doi.org\/10.1016\/j.humpath.2013.03.005","journal-title":"Hum Pathol"},{"issue":"11","key":"2679_CR42","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00256-015-2205-6","volume":"44","author":"C Jacquot","year":"2015","unstructured":"Jacquot C, Szymanska J, Nemana LJ, Steinbach LS, Horvai AE (2015) Soft-tissue aneurysmal bone cyst with translocation t(17;17)(p13;q21) corresponding to COL1A1 and USP6 loci. Skeletal Radiol 44(11):1695\u20131699. https:\/\/doi.org\/10.1007\/s00256-015-2205-6","journal-title":"Skeletal Radiol"},{"issue":"3","key":"2679_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/hupa.2003.41","volume":"34","author":"BM Wehrli","year":"2003","unstructured":"Wehrli BM, Huang W, De Crombrugghe B, Ayala AG, Czerniak B (2003) Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol 34(3):263\u2013269. https:\/\/doi.org\/10.1053\/hupa.2003.41","journal-title":"Hum Pathol"},{"issue":"1","key":"2679_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.anndiagpath.2009.09.003","volume":"14","author":"JC Fanburg-Smith","year":"2010","unstructured":"Fanburg-Smith JC, Auerbach A, Marwaha JS, Wang Z, Santi M, Judkins AR, Rushing EJ (2010) Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases. Ann Diagn Pathol 14(1):8\u201314. https:\/\/doi.org\/10.1016\/j.anndiagpath.2009.09.003","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"2679_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/jclinpath-2014-202601","volume":"68","author":"W Shon","year":"2015","unstructured":"Shon W, Folpe AL, Fritchie KJ (2015) ERG expression in chondrogenic bone and soft tissue tumours. J Clin Pathol 68(2):125\u2013129. https:\/\/doi.org\/10.1136\/jclinpath-2014-202601","journal-title":"J Clin Pathol"},{"key":"2679_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.humpath.2018.03.012","volume":"77","author":"AL Folpe","year":"2018","unstructured":"Folpe AL, Graham RP, Martinez A, Schembri-Wismayer D, Boland J, Fritchie KJ (2018) Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall. Hum Pathol 77:28\u201334. https:\/\/doi.org\/10.1016\/j.humpath.2018.03.012","journal-title":"Hum Pathol"},{"issue":"5","key":"2679_CR47","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00428-014-1627-1","volume":"465","author":"R Shibuya","year":"2014","unstructured":"Shibuya R, Matsuyama A, Nakamoto M, Shiba E, Kasai T, Hisaoka M (2014) The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465(5):599\u2013605. https:\/\/doi.org\/10.1007\/s00428-014-1627-1","journal-title":"Virchows Arch"},{"issue":"4","key":"2679_CR48","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/modpathol.2016.31","volume":"29","author":"YP Hung","year":"2016","unstructured":"Hung YP, Fletcher CD, Hornick JL (2016) Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma. Mod Pathol 29(4):370\u2013380. https:\/\/doi.org\/10.1038\/modpathol.2016.31","journal-title":"Mod Pathol"},{"issue":"2","key":"2679_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/gcc.20937","volume":"51","author":"L Wang","year":"2012","unstructured":"Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, Dal Cin P, Antonescu CR, Singer S, Hameed M, Bovee JV, Hogendoorn PC, Socci N, Ladanyi M (2012) Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 51(2):127\u2013139. https:\/\/doi.org\/10.1002\/gcc.20937","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"2679_CR50","doi-asserted-by":"publisher","first-page":"e49705","DOI":"10.1371\/journal.pone.0049705","volume":"7","author":"KB Nyquist","year":"2012","unstructured":"Nyquist KB, Panagopoulos I, Thorsen J, Haugom L, Gorunova L, Bjerkehagen B, Fossa A, Guriby M, Nome T, Lothe RA, Skotheim RI, Heim S, Micci F (2012) Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma. PLoS One 7(11):e49705. https:\/\/doi.org\/10.1371\/journal.pone.0049705","journal-title":"PLoS One"},{"issue":"3","key":"2679_CR51","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s11999-016-4779-2","volume":"475","author":"BA Schneiderman","year":"2017","unstructured":"Schneiderman BA, Kliethermes SA, Nystrom LM (2017) Survival in mesenchymal chondrosarcoma varies based on age and tumor location: a survival analysis of the SEER database. Clin Orthop Relat Res 475(3):799\u2013805. https:\/\/doi.org\/10.1007\/s11999-016-4779-2","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"2679_CR52","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/jso.24567","volume":"115","author":"Y Tsuda","year":"2017","unstructured":"Tsuda Y, Ogura K, Hakozaki M, Kikuta K, Ae K, Tsuchiya H, Iwata S, Ueda T, Kawano H, Kawai A (2017) Mesenchymal chondrosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study on 57 patients. J Surg Oncol 115(6):760\u2013767. https:\/\/doi.org\/10.1002\/jso.24567","journal-title":"J Surg Oncol"},{"issue":"3","key":"2679_CR53","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ejca.2014.11.007","volume":"51","author":"AM Frezza","year":"2015","unstructured":"Frezza AM, Cesari M, Baumhoer D, Biau D, Bielack S, Campanacci DA, Casanova J, Esler C, Ferrari S, Funovics PT, Gerrand C, Grimer R, Gronchi A, Haffner N, Hecker-Nolting S, Holler S, Jeys L, Jutte P, Leithner A, San-Julian M, Thorkildsen J, Vincenzi B, Windhager R, Whelan J (2015) Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. Eur J Cancer 51(3):374\u2013381. https:\/\/doi.org\/10.1016\/j.ejca.2014.11.007","journal-title":"Eur J Cancer"},{"key":"2679_CR54","doi-asserted-by":"publisher","unstructured":"Chung EB, Enzinger FM (1987) Extraskeletal osteosarcoma. Cancer 60(5):1132\u20131142. https:\/\/doi.org\/10.1002\/1097-0142(19870901)60:5<1132::AID-CNCR2820600536>3.0.CO;2-L","DOI":"10.1002\/1097-0142(19870901)60:5<1132::AID-CNCR2820600536>3.0.CO;2-L"},{"key":"2679_CR55","doi-asserted-by":"publisher","unstructured":"Bane BL, Evans HL, Ro JY, Carrasco CH, Grignon DJ, Benjamin RS, Ayala AG (1990) Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer 65(12):2762\u20132770. https:\/\/doi.org\/10.1002\/1097-0142(19900615)65:12<2762::AID-CNCR2820651226>3.0.CO;2-K","DOI":"10.1002\/1097-0142(19900615)65:12<2762::AID-CNCR2820651226>3.0.CO;2-K"},{"key":"2679_CR56","doi-asserted-by":"publisher","unstructured":"Lee JS, Fetsch JF, Wasdhal DA, Lee BP, Pritchard DJ, Nascimento AG (1995) A review of 40 patients with extraskeletal osteosarcoma. Cancer 76(11):2253\u20132259. https:\/\/doi.org\/10.1002\/1097-0142(19951201)76:11<2253::AID-CNCR2820761112>3.0.CO;2-8","DOI":"10.1002\/1097-0142(19951201)76:11<2253::AID-CNCR2820761112>3.0.CO;2-8"},{"issue":"5","key":"2679_CR57","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/00000478-199805000-00010","volume":"22","author":"M Lidang Jensen","year":"1998","unstructured":"Lidang Jensen M, Schumacher B, Myhre Jensen O, Steen Nielsen O, Keller J (1998) Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases. Am J Surg Pathol 22(5):588\u2013594. https:\/\/doi.org\/10.1097\/00000478-199805000-00010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2679_CR58","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.2106\/JBJS.M.00339","volume":"96","author":"LE Choi","year":"2014","unstructured":"Choi LE, Healey JH, Kuk D, Brennan MF (2014) Analysis of outcomes in extraskeletal osteosarcoma: a review of fifty-three cases. J Bone Joint Surg Am 96(1):e2. https:\/\/doi.org\/10.2106\/JBJS.M.00339","journal-title":"J Bone Joint Surg Am"},{"key":"2679_CR59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejca.2016.12.016","volume":"74","author":"A Longhi","year":"2017","unstructured":"Longhi A, Bielack SS, Grimer R, Whelan J, Windhager R, Leithner A, Gronchi A, Biau D, Jutte P, Krieg AH, Klenke FM, Grignani G, Donati DM, Capanna R, Casanova J, Gerrand C, Bisogno G, Hecker-Nolting S, De Lisa M, D'Ambrosio L, Willegger M, Scoccianti G, Ferrari S (2017) Extraskeletal osteosarcoma: a European Musculoskeletal Oncology Society study on 266 patients. Eur J Cancer 74:9\u201316. https:\/\/doi.org\/10.1016\/j.ejca.2016.12.016","journal-title":"Eur J Cancer"},{"issue":"1","key":"2679_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/cjp2.29","volume":"2","author":"G Jour","year":"2016","unstructured":"Jour G, Wang L, Middha S, Zehir A, Chen W, Sadowska J, Healey J, Agaram NP, Choi L, Nafa K, Hameed M (2016) The molecular landscape of extraskeletal osteosarcoma: a clinicopathological and molecular biomarker study. J Pathol Clin Res 2(1):9\u201320. https:\/\/doi.org\/10.1002\/cjp2.29","journal-title":"J Pathol Clin Res"},{"issue":"9","key":"2679_CR61","first-page":"906","volume":"115","author":"ES Yi","year":"1991","unstructured":"Yi ES, Shmookler BM, Malawer MM, Sweet DE (1991) Well-differentiated extraskeletal osteosarcoma. A soft-tissue homologue of parosteal osteosarcoma. Arch Pathol Lab Med 115(9):906\u2013909","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"2679_CR62","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.humpath.2005.01.023","volume":"36","author":"LC Abramovici","year":"2005","unstructured":"Abramovici LC, Hytiroglou P, Klein RM, Karkavelas G, Drevelegas A, Panousi E, Steiner GC (2005) Well-differentiated extraskeletal osteosarcoma: report of 2 cases, 1 with dedifferentiation. Hum Pathol 36(4):439\u2013443. https:\/\/doi.org\/10.1016\/j.humpath.2005.01.023","journal-title":"Hum Pathol"},{"key":"2679_CR63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.humpath.2017.02.007","volume":"63","author":"K Yamashita","year":"2017","unstructured":"Yamashita K, Kohashi K, Yamada Y, Nishida Y, Urakawa H, Oda Y, Toyokuni S (2017) Primary extraskeletal osteosarcoma: a clinicopathological study of 18 cases focusing on MDM2 amplification status. Hum Pathol 63:63\u201369. https:\/\/doi.org\/10.1016\/j.humpath.2017.02.007","journal-title":"Hum Pathol"},{"issue":"1","key":"2679_CR64","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/his.13506","volume":"73","author":"N Makise","year":"2018","unstructured":"Makise N, Sekimizu M, Kubo T, Wakai S, Watanabe SI, Kato T, Kinoshita T, Hiraoka N, Fukayama M, Kawai A, Ichikawa H, Yoshida A (2018) Extraskeletal osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity. Histopathology 73(1):147\u2013156. https:\/\/doi.org\/10.1111\/his.13506","journal-title":"Histopathology"},{"issue":"5","key":"2679_CR65","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/his.13421","volume":"72","author":"K Yamashita","year":"2018","unstructured":"Yamashita K, Kohashi K, Yamada Y, Ishii T, Nishida Y, Urakawa H, Ito I, Takahashi M, Inoue T, Ito M, Ohara Y, Oda Y, Toyokuni S (2018) Osteogenic differentiation in dedifferentiated liposarcoma: a study of 36 cases in comparison to the cases without ossification. Histopathology 72(5):729\u2013738. https:\/\/doi.org\/10.1111\/his.13421","journal-title":"Histopathology"},{"issue":"6","key":"2679_CR66","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1365-2559.2011.04070.x","volume":"59","author":"E Chen","year":"2011","unstructured":"Chen E, O'Connell F, Fletcher CD (2011) Dedifferentiated leiomyosarcoma: clinicopathological analysis of 18 cases. Histopathology 59(6):1135\u20131143. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.04070.x","journal-title":"Histopathology"},{"issue":"5","key":"2679_CR67","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.anndiagpath.2012.08.006","volume":"17","author":"K Thway","year":"2013","unstructured":"Thway K, Hayes A, Ieremia E, Fisher C (2013) Heterologous osteosarcomatous and rhabdomyosarcomatous elements in dedifferentiated solitary fibrous tumor: further support for the concept of dedifferentiation in solitary fibrous tumor. Ann Diagn Pathol 17(5):457\u2013463. https:\/\/doi.org\/10.1016\/j.anndiagpath.2012.08.006","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"2679_CR68","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00428-014-1625-3","volume":"465","author":"A Kurisaki-Arakawa","year":"2014","unstructured":"Kurisaki-Arakawa A, Akaike K, Hara K, Arakawa A, Takahashi M, Mitani K, Yao T, Saito T (2014) A case of dedifferentiated solitary fibrous tumor in the pelvis with TP53 mutation. Virchows Arch 465(5):615\u2013621. https:\/\/doi.org\/10.1007\/s00428-014-1625-3","journal-title":"Virchows Arch"},{"issue":"4","key":"2679_CR69","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/PAS.0000000000000564","volume":"40","author":"CN Prieto-Granada","year":"2016","unstructured":"Prieto-Granada CN, Wiesner T, Messina JL, Jungbluth AA, Chi P, Antonescu CR (2016) Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST. Am J Surg Pathol 40(4):479\u2013489. https:\/\/doi.org\/10.1097\/PAS.0000000000000564","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2679_CR70","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/PAS.0000000000001014","volume":"42","author":"N Makise","year":"2018","unstructured":"Makise N, Sekimizu M, Kubo T, Wakai S, Hiraoka N, Komiyama M, Fukayama M, Kawai A, Ichikawa H, Yoshida A (2018) Clarifying the distinction between malignant peripheral nerve sheath tumor and dedifferentiated liposarcoma: a critical reappraisal of the diagnostic utility of MDM2 and H3K27me3 status. Am J Surg Pathol 42(5):656\u2013664. https:\/\/doi.org\/10.1097\/PAS.0000000000001014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2679_CR71","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41379-018-0140-5","volume":"32","author":"N Makise","year":"2019","unstructured":"Makise N, Sekimizu M, Konishi E, Motoi T, Kubo T, Ikoma H, Watanabe SI, Okuma T, Hiraoka N, Fukayama M, Kawai A, Ichikawa H, Yoshida A (2019) H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features. Mod Pathol 32(3):435\u2013445. https:\/\/doi.org\/10.1038\/s41379-018-0140-5","journal-title":"Mod Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02679-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-019-02679-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02679-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T02:04:31Z","timestamp":1625450671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-019-02679-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["2679"],"URL":"https:\/\/doi.org\/10.1007\/s00428-019-02679-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"1 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}